SE9501472D0 - Truncated IGF-I - Google Patents
Truncated IGF-IInfo
- Publication number
- SE9501472D0 SE9501472D0 SE9501472A SE9501472A SE9501472D0 SE 9501472 D0 SE9501472 D0 SE 9501472D0 SE 9501472 A SE9501472 A SE 9501472A SE 9501472 A SE9501472 A SE 9501472A SE 9501472 D0 SE9501472 D0 SE 9501472D0
- Authority
- SE
- Sweden
- Prior art keywords
- igf
- truncated
- truncated variant
- expressing
- variant
- Prior art date
Links
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 title abstract 11
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 title abstract 11
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
- 210000005253 yeast cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a truncated variant of IGF-I having 1-69 of the amino acids of authentic IGF-I (IGF-I(1-69)) and a method of obtaining the truncated IGF-I either by expressing of IGF-I in yeast cells, enzymatic cleavage and thereafter isolating the truncated IGF-I from the medium or by introducing a plasmid encoding for the truncated variant of IGF-I and expressing the truncated variant of IGF-I. The invention also relates to a pharmaceutical composition containing this new truncated variant of IGF-I and to the use of IGF-I(1-69) for the preparation of a medicament.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9501472A SE9501472D0 (en) | 1995-04-21 | 1995-04-21 | Truncated IGF-I |
AU54129/96A AU5412996A (en) | 1995-04-21 | 1996-04-19 | Truncated igf-i |
PCT/SE1996/000520 WO1996033216A1 (en) | 1995-04-21 | 1996-04-19 | Truncated igf-i |
IL11790796A IL117907A0 (en) | 1995-04-21 | 1996-05-14 | Truncated IGF-I |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9501472A SE9501472D0 (en) | 1995-04-21 | 1995-04-21 | Truncated IGF-I |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9501472D0 true SE9501472D0 (en) | 1995-04-21 |
Family
ID=20398031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9501472A SE9501472D0 (en) | 1995-04-21 | 1995-04-21 | Truncated IGF-I |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU5412996A (en) |
IL (1) | IL117907A0 (en) |
SE (1) | SE9501472D0 (en) |
WO (1) | WO1996033216A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048964A (en) * | 1995-12-12 | 2000-04-11 | Stryker Corporation | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
US6121416A (en) | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
US6420518B1 (en) | 1997-04-04 | 2002-07-16 | Genetech, Inc. | Insulin-like growth factor agonist molecules |
SE9802938D0 (en) | 1998-09-01 | 1998-09-01 | Astra Ab | Improved stability for injection solutions |
DE60042550D1 (en) | 1999-01-06 | 2009-08-27 | Genentech Inc | MUTED VARIANTS OF THE INSULIN-SIMILAR GROWTH FACTOR I (IGF-I) |
AU762351B2 (en) | 1999-01-06 | 2003-06-26 | Genentech Inc. | Insulin-like growth factor (IGF) I mutant variants |
WO2000078341A1 (en) * | 1999-06-21 | 2000-12-28 | Murdoch Childrens Research Institute | A method for the prophylaxis and/or treatment of medical disorders |
ES2301547T3 (en) | 2000-05-16 | 2008-07-01 | Genentech, Inc. | TREATMENT OF CARTILAGO DISORDERS. |
EP1772464B1 (en) | 2001-02-09 | 2009-08-12 | Genentech, Inc. | Methods of identifying indirect agonists of IGF-1 |
WO2002072780A2 (en) | 2001-03-14 | 2002-09-19 | Genentech, Inc. | Igf antagonist peptides |
EP1667521B1 (en) | 2003-09-12 | 2011-12-07 | Tercica, Inc. | Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency |
WO2021005604A1 (en) | 2019-07-11 | 2021-01-14 | Opko Biologics Ltd. | Long-acting igf-1 or igf-1 variants and methods of producing same |
GB201913196D0 (en) | 2019-09-12 | 2019-10-30 | Univ Newcastle | Culture method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5126324A (en) * | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
GB9217696D0 (en) * | 1992-08-20 | 1992-09-30 | Agricultural & Food Res | Use of specific binding molecules |
SE9402332D0 (en) * | 1994-07-01 | 1994-07-01 | Pharmacia Ab | IGF-1 |
-
1995
- 1995-04-21 SE SE9501472A patent/SE9501472D0/en unknown
-
1996
- 1996-04-19 WO PCT/SE1996/000520 patent/WO1996033216A1/en active Application Filing
- 1996-04-19 AU AU54129/96A patent/AU5412996A/en not_active Abandoned
- 1996-05-14 IL IL11790796A patent/IL117907A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1996033216A1 (en) | 1996-10-24 |
IL117907A0 (en) | 1996-08-04 |
AU5412996A (en) | 1996-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0770139T3 (en) | A fungus in which the areA gene has been modified, as well as an areA gene from aspergillus oryzae | |
SE9501472D0 (en) | Truncated IGF-I | |
AU4200897A (en) | Novel host cells and methods of producing proteins | |
AU4981101A (en) | Subtilisin variants | |
IL157644A0 (en) | Method for the purification of a protein preparation with erythropoietin activity | |
WO1997010851A3 (en) | Nucleic acid delivery vehicle | |
AU3246300A (en) | Polypeptides having galactose oxidase activity and nucleic acids encoding same | |
EP0088195A3 (en) | Messenger rna, production and use thereof | |
CA2175797A1 (en) | Human kunitz-type protease inhibitors | |
ES8504458A1 (en) | Preparation of DNA sequences and DNA recombinant molecules coding for the cholera toxine units A and B, the products obtained and compositions containing the unit(s) obtained. | |
ATE234933T1 (en) | METHOD FOR PRODUCING D-AMINO ACIDS BY DIRECT FERMENTATION | |
AU3802595A (en) | Tripeptidyl aminopeptidase | |
ES2169225T3 (en) | STRESS TOLERANT MICRO-ORGANISM AND FERMENTATION PRODUCT PRODUCTION PROCEDURE. | |
AU4940096A (en) | Host cell expressing reduced levels of a metalloprotease and methods using the host cell in protein production | |
ATE85345T1 (en) | NEW CADIODILATIN FRAGMENT, PROCESS FOR ITS PRODUCTION AND ITS APPLICATION. | |
AU6745287A (en) | Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins | |
AU2529095A (en) | Vaccine against mycobacterial infections | |
AU7811000A (en) | Membrane translocating peptide drug delivery system | |
BR0014519A (en) | Signal sequences for the preparation of leu-herudin through e. coli in the culture medium | |
IL133832A0 (en) | Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin | |
HUP0203221A2 (en) | Genes encoding enzymes for lignin biosynthesis and uses thereof | |
AUPM772494A0 (en) | Improvements in production of proteins in host cells | |
AU6378994A (en) | Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter | |
EP2281892A3 (en) | Methods for producing polypeptides in respiratory-deficient Trichoderma cells | |
AU4944996A (en) | Dna fragment encoding d-amino acid oxidase |